QualityStocksNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) Gains Attention as ‘Men’s Fitness’ Highlights unbuzzd Trial Results
Quantum BioPharma (NASDAQ: QNTM) is gaining broader consumer exposure following a recent Men’s Fitness review of clinical trial results for unbuzzd, a supplement drink designed to support alcohol metabolism and mental alertness after drinking. The randomized, double-blind, placebo-controlled study involving 26 participants found significantly lower estimated blood alcohol concentrations at several time points, improved self-rated alertness and reduced headache severity compared with a placebo. Quantum retains a financial interest in the consumer product through a 7% royalty on sales until payments reach $250 million, followed by a 3% perpetual royalty, as well as an equity stake in the brand’s operator…